Preventing HIV in injection drug users: Exploring the tradeoffs between interventions

Socio-Economic Planning Sciences

Volumn 37, Issue 4, 2003, Pages 269-288

  Wilson, Amy R ^a   Kahn, James G ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Economic analysis; Epidemic modeling; HIV prevention; Injection drug users; Resource allocation

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0042326727     PISSN: 00380121     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0038-0121(02)00040-X     Document Type: Article

References (69)

1. Anderson J.E. Wilson R.W. Barker P. Doll L. Jones T.S. Holtgrave D. Prevalence of sexual and drug-related HIV risk behaviors in the US adult population: results of the 1996 national household survey on drug abuse Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 21 1999 148-156
2. Dinwiddie S.H. Cottler L. Compton W. Abdallah A.B. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment Drug and Alcohol Dependence 43 1996 1-11
3. Murrill C.S. Prevots D.R. Miller M.S. Linley L.A. Royalty J.E. Gwinn M. Incidence of HIV among injection drug users entering drug treatment programs in four US cities Journal of Urban Health 78 2001 152-161
4. Camacho L.M. Bartholomew N.G. Joe G.W. Simpson D.D. Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up Drug and Alcohol Dependence 47 1997 11-18
5. Holmberg S.D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas American Journal of public Health 86 1996 642-654
6. San Francisco HIV prevention plan. HIV Prevention Planning Council, San Francisco, Department of Public Health-AIDS Office. 2001.
7. Gibson D.R. Flynn N.M. McCarthy J.J. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users AIDS 13 1999 1807-1818
8. Carlson R.G. Wang J. Siegal H.A. Falck R.S. A preliminary evaluation of a modified needle-cleaning intervention using bleach among injection drug users AIDS Education and Prevention 10 1998 523-532
9. Gibson D.R. McCusker J. Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behavior in injecting drug users AIDS 12 1998 919-929
10. Holtgrave D.R. Kelly J.A. Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention American Journal of public Health 86 1996 1442-1445
11. Kotranski L. Semaan S. Collier K. Lauby J. Halbert J. Feighan K. Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users AIDS Education and Prevention 10 1998 19-33
12. McCoy H.V. McCoy C.B. Lai S. Effectiveness of HIV interventions among women drug users Women and Health 27 1998 49-66
13. Rietmeijer C.A. Kane M.S. Simons P.Z. Corby N.H. Wolitski R.J. Higgins D.L. Judson F.N. Cohn D.L. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program AIDS 10 1996 291-298
14. Sorensen J.L. London J. Heitzmann C. Gibson D.R. Morales E.S. Dumontet R. Acree M. Psychoeducational group approach: HIV risk reduction in drug users AIDS Education and Prevention 6 1994 95-112
15. Booth R.E. Crowley T.J. Zhang Y. Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users Drug and Alcohol Dependence 42 1996 11-20
16. Latkin C.A. Vlahov D. Anthony J.C. Cohn S. Mandell W. Nelson K.E. Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland International Journal of Addiction 27 1992 717-725
17. Longshore D. Annon J. Anglin M.D. Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles 1987 through 1995 Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 1998 64-72
18. Schutz C.G. Vlahov D. Anthony J.C. Graham N.M. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users Journal of Clinical Epidemiology 47 1994 191-195
19. Singer M. Himmelgreen D. Dushay R. Weeks M.R. Variation in drug injection frequency among out-of-treatment drug users in a national sample American Journal of Drug and Alcohol Abuse 24 1998 321-341
20. Des Jarlais D.C. Friedman S.R. Friedmann P. Wenston J. Sotheran J.L. Choopanya K. Vanichseni S. Raktham S. Goldberg D. Frischer M. HIV/AIDS-related behavior change among injecting drug users in different national settings AIDS 9 1995 611-617
21. Longshore D. Anglin M.D. Annon K. Hsieh S. Trends in self-reported HIV risk behavior: injection drug users in Los Angeles Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 6 1993 82-90
22. Watters J.K. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992 Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 7 1994 1276-1281
23. Kral A.H. Bluthenthal R.N. Lorvick J. Gee L. Bacchetti P. Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis Lancet 357 2001 1397-1401
24. Dearing J.W. Larson R.S. Randall L.M. Pope R.S. Local reinvention of the CDC HIV prevention community planning initiative Journal of Community Health 23 1998 113-126
25. Valdiserri R.O. Aultman T.V. Curran J.W. Community planning: a national strategy to improve HIV prevention programs Journal of Community Health 20 1995 87-100
26. Ruiz MS, Gable AR, Kaplan EH, Stoto MA, Fineberg HV, Trussel J. No time to lose: getting more from HIV prevention. Institute of Medicine, Committee on HIV Prevention Strategies in the United States, Washington, DC: National Academy Press, 2001.
27. Richter A. Brandeau M.L. Owens D.K. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users Medical Decision Making 19 1999 167-179
28. Kaplan E.H. Pollack H. Allocating HIV prevention resources Socio-Economic Planning Sciences 32 1998 257-263
29. Zaric G.S. Brandeau M.L. Optimal investment in a portfolio of HIV prevention programs Medical Decision Making 21 2001 391-408
30. Kahn JG, Washington AE, Showstack JA. Updated estimates of the impact and cost of HIV prevention in injection drug users. Report prepared for the Centers for Disease Control. Institute for Health Policy Studies, University of California, San Francisco, 1992.
31. Kaplan E.H. Economic analysis of needle exchange AIDS 9 1995 1113-1119
32. Cohen J.B. Hauer L.B. Wofsy C.B. Women and IV drugs: parenteral and heterosexual transmission of human immunodeficiency virus Journal of Drug Issues 19 1989 39-56
33. Des Jarlais D.C. Wish E. Friedman S.R. Stoneburner R. Yancovitz S.R. Mildvan D. el-Sadr W. Brady E. Cuadrado M. Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus: current trends in New York City New York State Journal of Medicine 87 1987 283-286
34. Friedland G.H. Klein R.S. Transmission of the human immunodeficiency virus New England Journal of Medicine 317 1987 1125-1135
35. Friedman S. Des Jarlais D. Neaigus A. Abdul-Quader A. Sotheran J. Sufian M. Tross S. Goldsmith D. AIDS and the new drug injector Nature (UK) 339 1989 333-334
36. Lewis D.K. Watters J.K. Sexual risk behavior among heterosexual intravenous drug users: ethnic and gender variations AIDS 5 1994 77-83
37. Barnett PG, Rodgers JH. The cost of US substance abuse treatment from national survey data. 1999 (unpublished data).
38. Norton E.C. Martin R.F. Wechsberg W.M. Threshold analysis of AIDS outreach and intervention Holtgrave D.R. Handbook of economic evaluation of HIV prevention programs 1998 Plenum Press New York
39. Des Jarlais D.C. Friedmann P. Hagan H. Friedman S.R. The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study American Journal of public Health 86 1996 1780-1785
40. Kaplan E.H. Modeling HIV infectivity: must sex acts be counted? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 3 1990 55-61
41. Battjes R.J. Pickens R.W. Brown L.S.J. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 1995 90-96
42. Paone D. Des Jarlais D.C. Caloir S. Jose B. Shi Q. Friedman S.R. Continued risky injection subsequent to syringe exchange use among injection drug users in New York City AIDS Education and Prevention 9 1997 505-510
43. Smith K.W. McGraw S.A. Costa L.A. McKinlay J.B. A self-efficacy scale for HIV risk behaviors: development and evaluation AIDS Education and Prevention 8 1996 97-105
44. Wilson AR, Kahn JG. Preventing HIV in injection drug users: choosing the best mix of interventions for the population (unpublished) data 2002.
45. Ball J, Corty E, Bond H, Myers C, Tommasello A. The reduction of intravenous heroin use non-opiate abuse and crime during methadone maintenance treatment: further findings. Problems of drug dependence 1987. In: Harris LS, editor. NIDA Research Monograph 81, National Institute on Drug Abuse, Rockville, MD, 1988.
46. Ball J.C. Lange W.R. Myers P.C. Friedman S.R. Reducing the risk of AIDS through methadone maintenance treatment Journal of Health and Social Behavior 29 1988 214-226
47. Camacho L.M. Bartholomew N.G. Joe G.W. Cloud M.A. Simpson D.D. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance Drug and Alcohol Dependence 41 1996 1-7
48. Sisk JE, Hatziandreu EJ, Hughes R. The effectiveness of drug abuse treatment: implications for controlling AIDS/HIV infection (background paper 6). Office of Technology Assessment, Series on AIDS-Related Issues, 1990.
49. Booth R.E. Kwiatkowski C.F. Stephens R.C. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users Journal of Psychoactive Drugs 30 1998 269-278
50. Iguchi MY, Bux DA, Platt JJ, Lidz V, Kushner H, Baxter R, French J. Reduction in high-risk behaviors in IDUs at 6-month follow-up. In: Poster presentation at the Third Annual National AIDS Demonstration Research Project, 1991 (unpublished data).
51. Watters J.K. Downing M. Case P. Lorvick J. Cheng Y. Fergusson B. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior American Journal of Community Psychology 18 1990 587-596
52. Wiebel W.W. Jimenez A. Johnson W. Ouellet L. Jovanovic B. Lampinen T. Murray J. O'Brien M.U. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12 1996 282-289
53. Zaric G.S. Barnett P.G. Brandeau M.L. HIV transmission and the cost-effectiveness of methadone maintenance American Journal of public Health 90 2000 1100-1111
54. Zaric G.S. Brandeau M.L. Barnett P.G. Methadone maintenance and HIV prevention: a cost-effectiveness analysis Management Science 46 2000 1013-1031
55. Pollack H. Methadone treatment as HIV prevention: cost-effectiveness analysis Kaplan E.H. Brookmeyer R. Quantitative evaluation of HIV prevention programs 2002 Yale University Press New Haven
56. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. MMWR, Morbidity and Mortality Weekly Report, vol. 39, 1990. p. 1-18.
57. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop, Part I, AIDS, vol. 8, 1994, p. 911-21.
58. Abdul-Quader A.S. Friedman S.R. Des Jarlais D.C. Marmor M.M. Bartelme M. Methadone maintenance and behavior by intravenous drug users that can transmit HIV Contemporary Drug Problems 3 1987 425-434
59. Des Jarlais D.C. Friedman S.R. Marmor M. Cohen H. Mildvan D. Yancovitz S. Mathur U. el-Sadr W. Spira T.J. Garber J. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users AIDS 1 1987 105-111
60. Des Jarlais D.C. Friedman S.R. Sotheran J.L. Wenston J. Marmor M. Yancovitz S.R. Frank B. Beatrice S. Mildvan D. Continuity and change within an HIV epidemic: injecting drug users in New York City 1984-1992 Journal of American Medical Association 271 1994 121-127
61. Des Jarlais D.C. Perlis T. Friedman S.R. Deren S. Chapman T. Sotheran J.L. Tortu S. Beardsley M. Paone D. Torian L.V. Beatrice S.T. DeBernardo E. Monterroso E. Marmor M. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996 American Journal of public Health 88 1998 1801-1806
62. Gleghorn A.A. Doherty M.C. Vlahov D. Celentano D.D. Jones T.S. Inadequate bleach contact times during syringe cleaning among injection drug users Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 7 1994 767-772
63. Haverkos H.W. Battjes R.J. Female-to-male transmission of HIV. (letter) Journal of American Medical Association 268 1992 1855-1856
64. Henderson D.K. Fahey B.J. Willy M. Schmitt J.M. Carey K. Koziol D.E. Lane H.C. Fedio J. Saah A.J. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: A prospective evaluation Annals of Internal Medicine 113 1990 740-746
65. Hser Y. Anglin M.D. Powers K.I. A 24-year follow-up of California narcotics addicts Archives of General Psychiatry 50 1993 577-584
66. Kahn JG. Are NEPs cost-effective in preventing HIV infection? In: Lurie P, Reingold AL, editors. The public health impact of needle exchange programs in the United States and abroad. School of Public Health, University of California, Berkeley, and Institute for Health Policy Studies, University of California, San Francisco, 1993.
67. Vaillant G.E. The natural history of narcotic drug addiction Seminars in Psychiatry 2 1970 486-498
68. Vlahov D. Munoz A. Celentano D.D. Cohn S. Anthony J.C. Chilcoat H. Nelson K.E. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland Epidemiology 2 1991 444-446
69. Watters J.K. Jones T.S. Shapshak P. McCoy C.B. Flynn N. Gleghorn A. Vlahov D. Household bleach as disinfectant for use by injecting drug users Lancet 342 1993 742-743